Published in Expert Rev Mol Diagn on July 01, 2004
Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol (2010) 2.13
Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn (2005) 1.92
Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol (2009) 1.87
Nanotechnology: potential applications in urology. BJU Int (2006) 1.56
Video-games station or minimally invasive skills training station? BJU Int (2009) 1.43
Benign prostatic hyperplasia: solutions to an ageing problem. Hosp Med (2002) 1.43
Nanotechnology and its relevance to the urologist. Eur Urol (2007) 1.38
The metastatic cascade in prostate cancer. Surg Oncol (2006) 1.30
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol (2012) 1.18
Part I: Primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 1.08
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer (2013) 1.08
A new model for suprapubic catheterization: the MediPlus Seldinger suprapubic catheter. Expert Rev Med Devices (2008) 1.08
Is it worth revisiting laparoscopic three-dimensional visualization? A validated assessment. Urology (2007) 1.05
Molecular and genetic pathways in penile cancer. Lancet Oncol (2007) 0.93
Current challenges in Wilms' tumor management. Nat Clin Pract Oncol (2005) 0.92
Greenlight prostatectomy: a challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech (2007) 0.92
Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol (2007) 0.86
Focal cryotherapy of localized prostate cancer: a systematic review of the literature. Expert Rev Anticancer Ther (2014) 0.85
Molecular prognostic factors in penile cancer. World J Urol (2008) 0.85
ProstaScint and its role in the diagnosis of prostate cancer. Expert Rev Mol Diagn (2007) 0.84
'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases. BJU Int (2004) 0.83
Giant bladder stone and a rare complication. Br J Hosp Med (Lond) (2012) 0.83
Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol (2006) 0.82
The Dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol (2009) 0.81
Part II: Treatment of primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 0.81
Targeting vascular endothelial growth factor in renal cell carcinoma. Tumour Biol (2009) 0.81
Long-term follow-up after retroperitoneal laparoscopic decortication of symptomatic renal cysts. Urol Int (2007) 0.80
Expanding role of chemokines and their receptors in cancer. Expert Rev Anticancer Ther (2003) 0.80
The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics. Expert Opin Pharmacother (2006) 0.79
Nanotechnology in the management of prostate cancer. BJU Int (2008) 0.79
Management of small indeterminate renal tumours: is there a case for needle biopsy? BJU Int (2007) 0.78
Erectile dysfunction. BMJ (2014) 0.78
Tissue microarrays and their relevance to the urologist. J Urol (2006) 0.78
Testicular cancer: current update and controversies. Hosp Med (2002) 0.77
Is there a role for cardiopulmonary exercise testing before major urological surgery. BJU Int (2009) 0.77
Peyronie's disease: an update of the medical management. Expert Opin Pharmacother (2004) 0.77
Priapism--a review of the medical management. Expert Opin Pharmacother (2003) 0.76
Current status of robotic surgery in pediatric urology. Pediatr Surg Int (2008) 0.76
New phosphodiesterase inhibitors in the treatment of erectile dysfunction. Expert Opin Pharmacother (2004) 0.76
Intraluminal robotics: a new dawn in minimally invasive surgery? BJU Int (2008) 0.76
A training model for suprapubic catheter insertion: the UroEmerge suprapubic catheter model. Urology (2008) 0.76
Technological aspects of delivering cryotherapy for prostate cancer. Expert Rev Med Devices (2015) 0.76
Natural orifice transluminal endoscopic surgery: a new dimension in minimally invasive surgery. Expert Rev Gastroenterol Hepatol (2008) 0.76
A new training model for adult circumcision. J Surg Educ (2012) 0.76
Luteinising hormone releasing hormone analogues in the treatment of prostate cancer. Expert Opin Pharmacother (2002) 0.76
Re: The pharmacological management of intermittent priapismic states. BJU Int (2009) 0.75
Management of testicular torsion. J R Soc Med (2002) 0.75
Epistaxis after sildenafil. J R Soc Med (2002) 0.75
Authors' reply to Bunker. BMJ (2013) 0.75
Abdominal aortic aneurysm. Br J Gen Pract (2002) 0.75
WWW; the wild, wild web: internet usage in patients with urological cancer. BJU Int (2007) 0.75
Endoscopic ablation: Irreversible tide of technological advancement? BMJ (2008) 0.75
Hypoandrogen-metabolic syndrome: A significant issue for men's health. BJU Int (2006) 0.75
Orthotopic ileal neobladder: the influence of reservoir volume and configuration on urinary continence and emptying properties. BJU Int (2004) 0.75
Alternative use of botulinum toxin in urology. Expert Opin Pharmacother (2004) 0.75
Current trends in the management of Wilms' tumour. BJU Int (2006) 0.75
Radiommunotherapy and prostate cancer: a promising new therapy in the management of metastatic disease. BJU Int (2006) 0.75
Hormone therapy: a revolution in understanding prostate cancer. Lancet Oncol (2008) 0.75
Bladder cancer: a current update. Hosp Med (2003) 0.75
Robotic versus nonrobotic surgery: experts, toys and prostatectomy. Expert Rev Anticancer Ther (2008) 0.75
Molecular markers in penile cancer. Curr Probl Cancer (2015) 0.75
Non-myeloablative allogeneic stem cell transplantation: a promising new therapy in the management of metastatic renal cell cancer. BJU Int (2005) 0.75
Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets. Expert Rev Anticancer Ther (2005) 0.75
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy. Expert Opin Pharmacother (2006) 0.75
The intravenous urogram. Br J Hosp Med (Lond) (2006) 0.75
Three-dimensional visualization in laparoscopic surgery. BJU Int (2006) 0.75
Diagnosis and management of renal (ureteric) colic. Br J Hosp Med (Lond) (2006) 0.75
Impact of nanotechnology in breast cancer. Expert Rev Anticancer Ther (2009) 0.75
Urological emergency: diagnosis and management of renal trauma. Br J Hosp Med (Lond) (2005) 0.75
Expanding role of nanotechnology in the management of colorectal cancer. Expert Rev Anticancer Ther (2009) 0.75
The phosphodiesterase inhibitors and non-arteritic anterior ischaemic optic neuropathy: increased vigilance is necessary. BJU Int (2007) 0.75
Vasectomy illustrated. BJU Int (2012) 0.75
Laparoscopic cryotherapy for renal tumours. BJU Int (2012) 0.75
Current concepts in the pharmacotherapy of benign prostatic hyperplasia. Expert Opin Pharmacother (2002) 0.75
The artificial urinary sphincter. Expert Rev Med Devices (2007) 0.75
Robotic surgery: the coming of a new era in surgical innovation. Expert Rev Anticancer Ther (2005) 0.75
The ligated ureter: beware or be aware. Br J Hosp Med (Lond) (2006) 0.75
Anti-emetic therapy: updating urological cancer-care providers. BJU Int (2006) 0.75
Autonomic dysreflexia: the forgotten medical emergency. Hosp Med (2005) 0.75
Incidental urinary tract pathologies in the one-stop prostate cancer clinic. Arch Ital Urol Androl (2010) 0.75
Robotic telemanipulating surgical systems for laparoscopy: the story so far in the UK. Expert Rev Med Devices (2010) 0.75
An update on the use of 5alpha-reductase inhibitors. Drugs Today (Barc) (2004) 0.75
Multidisciplinary teamwork in urological oncology. Expert Rev Anticancer Ther (2006) 0.75
Allogeneic stem-cell transplantation for renal-cell cancer. Lancet Oncol (2004) 0.75
An image-based technique for aiding tumour excision during laparoscopic partial nephrectomy. BJU Int (2010) 0.75
Giant nonfunctioning carcinoma of the adrenal cortex mimicking renal cell carcinoma: a diagnostic dilemma. Urology (2007) 0.75
Photodynamic diagnostic cystoscopy. BJU Int (2012) 0.75
Key papers in prostate cancer. Expert Rev Anticancer Ther (2014) 0.75